NUVASIVE INC 4

4 · NUVASIVE INC · Filed Mar 9, 2017

Form 4

Period: 2017-03-07

SVP and General Counsel

Transactions

Tax Payment
Common Stock
2017-03-07$74.63/sh−72,535$5,413,287→ 69,801 total
Exercise/Conversion
Common Stock
2017-03-07$34.82/sh+97,375$3,390,598→ 142,336 total
Sale
Common Stock
2017-03-08$74.21/sh−24,340$1,806,271→ 45,461 total
Sale
Common Stock
2017-03-08$74.80/sh−500$37,400→ 44,961 total
Exercise/Conversion
Employee Stock Option (Right to Buy)
2017-03-07−97,375→ 0 total
Exercise: $34.82Exp: 2019-01-02→ Common Stock (97,375 underlying)

Footnotes (6)

[F1]Shares directly held by the Reporting Person. The Reporting Person also holds conditional rights to receive shares pursuant to previously disclosed Issuer equity awards.
[F2]Payment of exercise price and tax liability by Issuer's withholding of shares incident to the respective option exercise.
[F3]Sales effected pursuant to a 10b5-1 Trading Plan adopted by the Reporting Person, which is intended to comply with Rule 10b5-1.
[F4]Weighted average sales price from sales transactions ranging from $73.71 to $74.70. Upon request by the Commission staff or a security holder of the Issuer, either the Issuer or the Reporting Person will undertake to provide full information regarding the number of shares sold at each separate price.
[F5]Weighted average sales price from sales transactions ranging from $74.74 to $74.91. Upon request by the Commission staff or a security holder of the Issuer, either the Issuer or the Reporting Person will undertake to provide full information regarding the number of shares sold at each separate price.
[F6]The option, representing a right to purchase a total of 97,375 shares, was granted on January 2, 2009 and is fully vested.

Documents

1 file